| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.7 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |